Conference · London, United Kingdom
Quantitative Benefit-Risk Assessment for the New PSUR
Health · Medicine · Pharmaceuticals
Key numbers
- Editions on record
- 1first in 2014
About Quantitative Benefit-Risk Assessment for the New PSUR
The latest legislation waives the obligation to submit PSURs routinely for generic products, well-established use products, homoeopathic products, and traditional herbal products. The submission frequency will be variable and risk based. For these, PSURs shall be submitted where there is a condition in the MA or when requested by a Competent Authority on the basis of concerns relating to pharmacovigilance data or due to the absence of PSURs for an active substance after its authorisation.
From our listing of this edition. Details may have changed since.
Editions
| Year | Dates | Where | Exhibitors | Visitors |
|---|---|---|---|---|
| 2014 | 14 Apr 2014 | Holiday Inn London Bloomsbury London, United Kingdom | — | — |
Past editions from the bvents archive (2008–2019) and organiser figures where they were published.
Questions
When is Quantitative Benefit-Risk Assessment for the New PSUR?
The next dates haven't been confirmed. The last edition we have on record was 14 Apr 2014.
Where is it held?
The last edition we have was at Holiday Inn London Bloomsbury, London, United Kingdom.